Relationship of paroxysmal atrial achyarrhythmias to volume overload: Assessment by implanted transpulmonary impedance monitoring

Circulation: Arrhythmia and Electrophysiology

Volumn 2, Issue 5, 2009, Pages 488-494

  Benditt, David G ^a,b   Jhanjee, Rajat ^a   Templeton, Grant A ^a   Sattiraju, Srinivasan ^a   Nguyen, John ^a   Sakaguchi, Scott ^a   Lu, Fei ^a   Ermis, Cengiz ^a   Milstein, Simon ^a,b   Van Heel, Laura ^b   Lurie, Keith G ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Central Minnesota Heart Center   (United States)

Author keywords

Atrial tachyarrhythmias; Bioimpedance; Heart failure; Volume overload

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ATRIUM ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYDROTHORAX; IMPEDANCE; INCIDENCE; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MONITORING; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUPRAVENTRICULAR TACHYCARDIA; SYSTOLIC DYSFUNCTION; TRANSPULMONARY ELECTRICAL BIOIMPEDANCE;

AGED; ALGORITHMS; ATRIAL FIBRILLATION; BLOOD VOLUME; CARDIOGRAPHY, IMPEDANCE; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 74549224588     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.109.860221     Document Type: Article

References (30)

1. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920-2925.
2. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-952.
3. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995;155:469-473.
4. Van Den Berg MP, Tuinenburg AE, Crijns HJGM, Van Gelder ICV, Gosselink ATM, Lie KI. Heart failure and atrial fibrillation: current concepts and controversies. Heart. 1997;77:309-313.
5. Cha YM, Redfield MM, Shen WK, Gersh BJ. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation. 2004;109:2839-2843.
6. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003; 91(Suppl):2D-8D.
7. Daubert JC. Introduction to atrial fibrillation and heart failure: a mutually noxious association. Europace. 2004;5(Suppl):S1-S4.
8. Munir SM, Bogaev RC, Sobash E, Shankar KJ, Gondi S, Stupin IV, Robertson J, Brewer MA, Casscells SW, Delgado RM, Ahmed A. Devices in heart failure. Texas Heart Inst J. 2008;35:166-173.
9. Wang L. Fundamentals of intra-thoracic impedance monitoring in heart failure. Am J Cardiol. 2007;99 (Suppl):3G-10G.
10. Yu C, Wang L, Chau E, Chan RH, Kong S, Tang M, Christensen J, Stadler RW, Lau C. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005;112:841-848.
11. Vollmann D, Nägele H, Schauerte P, Wiegand U, Butter C, Zanotto G, Quesada A, Guthmann A, Hill MR, Lamp B. European InSync Sentry Observational Study Investigators. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J. 2007;28:1835-1840.
12. Maines M, Catanzariti D, Cemin C, Vaccarini C, Vergara G. Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: a case-control study. J Interv Card Electrophysiol. 2007; 19:201-207.
13. Lüthje L, Vollmann D, Drescher T, Schott P, Zenker D, Hasenfuss G, Unterberg C. Intrathoracic impedance monitoring to detect chronic heart failure deterioration: relationship to changes in NT-proBNP. Eur J Heart Fail. 2007;9:716-722. (Pubitemid 46702828)
14. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population based cohort: the Framingham Heart Study. JAMA. 1994;271:840-844.
15. Wijffels MC, Kirchof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 1995;92:1954-1968.
16. Li D, Shinagawa K, Pang L, Leung TK, Cardin, Wang SZ, Nattel S. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacinginduced congestive heart failure. Circulation. 2001;104: 2608-2614.
17. Waldo AL. Mechanisms of atrial fibrillation. J Cardiovasc Electrophysiol. 2003;14:S267-S274.
18. Solti F, Vecsey T, Kekesi V, Juhasz-Nagy A. The effect of atrial dilatation on the genesis of atrial arrhythmia. Cardiovasc Res. 1989;23: 882-886.
19. Andriulli J, Coles J, Hettrick DA. Association between decreased intrathoracic impedance and ventricular tachyarrhythmias. Int J Cardiol. 2008 24;123:333-334.
20. 2+ channel abnormalities: cause, consequence, or innocent bystander? Circ Res. 1999;85: 473-476.
21. Clark M, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30:1039-1045.
22. Tomaselli GF, Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res. 1999;42:270-283.
23. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies: the V-HeFT VA Cooperative Studies Group Circulation. 1993;87(Suppl VI):VI-102-VI-110.
24. Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT). Circulation. 1998;98:2574-2579.
25. Torp-Pedersen C, Møller M, Bloch-Thomsen PE, Køber L, Sandøe E, Egstrup K, Agner E, Carlsen J, Videbaek J, Marchant B, Camm AJ. Dofetilide in patients with congestive heart failure and left ventricular dysfunction: Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med. 1999;341:857-865.
26. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol. 1997;29:709-715.
27. Fenelon G, Wijns W, Andries E, Brugada P. Tachycardiomyopathy: mechanisms and clinical implications. Pacing Clin Electrophysiol. 1996; 19:95-106.
28. Efremidis M, Pappas L, Filippatos G. Management of atrial fibrillation in patients with heart failure. J Card Fail. 2008;14:232-237.
29. Savelieva I, Camm J. Update on atrial fibrillation: Part I. Clin Cardiol. 2008;31:55-62.
30. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O'Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL. Atrial Fibrillation and Congestive Heart Failure Investigators: rhythm control vs rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358:2667-2677.